Edition:
India

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

42.99USD
26 Jun 2019
Change (% chg)

$-0.77 (-1.76%)
Prev Close
$43.76
Open
$43.62
Day's High
$43.79
Day's Low
$42.54
Volume
8,372,925
Avg. Vol
6,833,481
52-wk High
$46.46
52-wk Low
$36.03

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $243,302.50
Shares Outstanding(Mil.): 5,559.93
Dividend: 0.36
Yield (%): 3.29

Financials

  PFE.N Industry Sector
P/E (TTM): 24.23 32.49 37.22
EPS (TTM): 1.81 -- --
ROI: 8.15 12.55 12.18
ROE: 16.55 13.86 17.03

RPT-BUZZ-U.S. stocks weekly: Asset grab

(Repeats from Friday. Updates chart) ** S&P 500 extends win streak to three weeks, adds 2.2%. Rate-cut euphoria and trade optimism spur index to record highs. Bonds and commodities also catch bids ** Indeed, studies suggested sudden quiet could end with a bang ** And as the SPX went for a second round with resistance , the Dow caught a second wind ** Now the Dow is trying to make the big leap as the SPX notched a "defensive" new high ** Every sector rises: Energy and tech s

24 Jun 2019

BUZZ-U.S. stocks weekly: Asset grab

** S&P 500 extends win streak to three weeks, adds 2.2%. Rate-cut euphoria and trade optimism spur index to record highs. Bonds and commodities also catch bids ** Indeed, studies suggested sudden quiet could end with a bang ** And as the SPX went for a second round with resistance , the Dow caught a second wind ** Now the Dow is trying to make the big leap as the SPX notched a "defensive" new high ** Every sector rises: Energy and tech surge, while defensive sectors notch ga

22 Jun 2019

GSK offers concessions to address EU concerns over Pfizer deal

BRUSSELS GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.

20 Jun 2019

GSK offers concessions to address EU concerns over Pfizer deal

BRUSSELS, June 20 GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.

20 Jun 2019

PRESS DIGEST - Wall Street Journal - June 18

June 18 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

18 Jun 2019

Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma

Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.

18 Jun 2019

Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma

Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.

18 Jun 2019

Faith in the Fed nudges Wall Street higher

Wall Street edged higher on Monday, supported by Facebook, Amazon and Apple, as investors awaited a key Federal Reserve meeting that is expected to lay the groundwork for an interest rate cut later this year. | Video

18 Jun 2019

US STOCKS-Faith in the Fed nudges Wall Street higher

* Indexes end higher: Dow 0.09%, S&P 500 0.09%, Nasdaq 0.62% (Updated to close)

18 Jun 2019

US STOCKS-Faith in the Fed pushes Wall Street higher

* Indexes up: Dow 0.17%, S&P 500 0.23%, Nasdaq 0.79% (Updated to afternoon)

18 Jun 2019

Earnings vs. Estimates